APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gamma Valerolactone

Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.

Selected research

Market Outlook & Growth Opportunities

Global Gamma Valerolactone Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchGamma Valerolactone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma Valerolactone Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gamma Valerolactone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma Valerolactone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma Valerolactone Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.

Global Gamma Valerolactone (CAS 108-29-2) key players include Anhui Hyea Aromas, Dideu Industries, Kunshan Qiandeng Baihua, etc. Global top three manufacturers hold a share over 75%.

China is the largest market, with a share over 85%, followed by Japan, and USA, both have a share about 10 percent.

Read the full market overview

In terms of product, Food Grade is the largest segment, with a share nearly 75%. And in terms of application, the largest application is Food Flavors, followed by Monomer Intermediate, Solvents, etc.

This report provides an overview of the global Gamma Valerolactone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gamma Valerolactone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gamma Valerolactone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gamma Valerolactone market size, projected growth trends, production technologies, key applications, and end-use industries.

Gamma Valerolactone Segment by Company

Anhui Hyea Aromas

Dideu Industries

Kunshan Qiandeng Baihua

Zhongyue Aroma

Soda Aromatic

Inoue Perfumery MFG

Gamma Valerolactone Segment by Type

Food Grade

Industrial Grade

Gamma Valerolactone Segment by Application

Food Flavors

Solvent

Monomer Intermediate

Others

Gamma Valerolactone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gamma Valerolactone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gamma Valerolactone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gamma Valerolactone significant trends, drivers, influence factors in global and regions.

6. To analyze Gamma Valerolactone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma Valerolactone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma Valerolactone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma Valerolactone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gamma Valerolactone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma Valerolactone industry.

Chapter 3: Detailed analysis of Gamma Valerolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gamma Valerolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gamma Valerolactone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gamma Valerolactone Industry Trends Table 2. Gamma Valerolactone Industry Drivers Table 3. Gamma Valerolactone Industry Opportunities and Challenges Table 4. Gamma Valerolactone Industry Restraints Table 5. Global Gamma Valerolactone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gamma Valerolactone Revenue Share by Company (2021-2026) Table 7. Global Gamma Valerolactone Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Gamma Valerolactone Sales Volume Share by Company (2021-2026) Table 9. Global Gamma Valerolactone Average Price (K USD/Kg) of Company (2021-2026) Table 10. Global Gamma Valerolactone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gamma Valerolactone Key Company Manufacturing Base & Headquarters Table 12. Global Gamma Valerolactone Company, Product Type & Application Table 13. Global Gamma Valerolactone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gamma Valerolactone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Food Grade Table 18. Significant Companies of Industrial Grade Table 19. Global Gamma Valerolactone Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Gamma Valerolactone Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Gamma Valerolactone Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Gamma Valerolactone Sales Volume Share by Type (2021-2026) Table 23. Global Gamma Valerolactone Sales Volume Share by Type (2027-2032) Table 24. Global Gamma Valerolactone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gamma Valerolactone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gamma Valerolactone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gamma Valerolactone Sales Value Share by Type (2021-2026) Table 28. Global Gamma Valerolactone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Food Flavors Table 30. Significant Companies of Solvent Table 31. Significant Companies of Monomer Intermediate Table 32. Significant Companies of Others Table 33. Global Gamma Valerolactone Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Gamma Valerolactone Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Gamma Valerolactone Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Gamma Valerolactone Sales Volume Share by Application (2021-2026) Table 37. Global Gamma Valerolactone Sales Volume Share by Application (2027-2032) Table 38. Global Gamma Valerolactone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gamma Valerolactone Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Gamma Valerolactone Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Gamma Valerolactone Sales Value Share by Application (2021-2026) Table 42. Global Gamma Valerolactone Sales Value Share by Application (2027-2032) Table 43. Global Gamma Valerolactone Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Gamma Valerolactone Sales by Region (2021-2026) & (Kg) Table 45. Global Gamma Valerolactone Sales Market Share by Region (2021-2026) Table 46. Global Gamma Valerolactone Sales by Region (2027-2032) & (Kg) Table 47. Global Gamma Valerolactone Sales Market Share by Region (2027-2032) Table 48. Global Gamma Valerolactone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gamma Valerolactone Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Gamma Valerolactone Sales Value Share by Region (2021-2026) Table 51. Global Gamma Valerolactone Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Gamma Valerolactone Sales Value Share by Region (2027-2032) Table 53. Global Gamma Valerolactone Market Average Price (K USD/Kg) by Region (2021-2026) Table 54. Global Gamma Valerolactone Market Average Price (K USD/Kg) by Region (2027-2032) Table 55. Global Gamma Valerolactone Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Gamma Valerolactone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Gamma Valerolactone Sales by Country (2021-2026) & (Kg) Table 58. Global Gamma Valerolactone Sales Market Share by Country (2021-2026) Table 59. Global Gamma Valerolactone Sales by Country (2027-2032) & (Kg) Table 60. Global Gamma Valerolactone Sales Market Share by Country (2027-2032) Table 61. Global Gamma Valerolactone Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Gamma Valerolactone Sales Value Market Share by Country (2021-2026) Table 63. Global Gamma Valerolactone Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Gamma Valerolactone Sales Value Market Share by Country (2027-2032) Table 65. Anhui Hyea Aromas Company Information Table 66. Anhui Hyea Aromas Business Overview Table 67. Anhui Hyea Aromas Gamma Valerolactone Sales (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2021-2026) Table 68. Anhui Hyea Aromas Gamma Valerolactone Product Portfolio Table 69. Anhui Hyea Aromas Recent Development Table 70. Dideu Industries Company Information Table 71. Dideu Industries Business Overview Table 72. Dideu Industries Gamma Valerolactone Sales (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2021-2026) Table 73. Dideu Industries Gamma Valerolactone Product Portfolio Table 74. Dideu Industries Recent Development Table 75. Kunshan Qiandeng Baihua Company Information Table 76. Kunshan Qiandeng Baihua Business Overview Table 77. Kunshan Qiandeng Baihua Gamma Valerolactone Sales (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2021-2026) Table 78. Kunshan Qiandeng Baihua Gamma Valerolactone Product Portfolio Table 79. Kunshan Qiandeng Baihua Recent Development Table 80. Zhongyue Aroma Company Information Table 81. Zhongyue Aroma Business Overview Table 82. Zhongyue Aroma Gamma Valerolactone Sales (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2021-2026) Table 83. Zhongyue Aroma Gamma Valerolactone Product Portfolio Table 84. Zhongyue Aroma Recent Development Table 85. Soda Aromatic Company Information Table 86. Soda Aromatic Business Overview Table 87. Soda Aromatic Gamma Valerolactone Sales (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2021-2026) Table 88. Soda Aromatic Gamma Valerolactone Product Portfolio Table 89. Soda Aromatic Recent Development Table 90. Inoue Perfumery MFG Company Information Table 91. Inoue Perfumery MFG Business Overview Table 92. Inoue Perfumery MFG Gamma Valerolactone Sales (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2021-2026) Table 93. Inoue Perfumery MFG Gamma Valerolactone Product Portfolio Table 94. Inoue Perfumery MFG Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Gamma Valerolactone Distributors List Table 98. Gamma Valerolactone Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Gamma Valerolactone Product Image Figure 2. Global Gamma Valerolactone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gamma Valerolactone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gamma Valerolactone Sales (2021-2032) & (Kg) Figure 5. Global Gamma Valerolactone Sales Average Price (K USD/Kg) & (2021-2032) Figure 6. Global Gamma Valerolactone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Food Grade Image Figure 10. Industrial Grade Image Figure 11. Global Gamma Valerolactone Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Gamma Valerolactone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gamma Valerolactone Sales Volume Share by Type (2021-2032) Figure 14. Global Gamma Valerolactone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gamma Valerolactone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gamma Valerolactone Sales Value Share by Type (2021-2032) Figure 17. Food Flavors Image Figure 18. Solvent Image Figure 19. Monomer Intermediate Image Figure 20. Others Image Figure 21. Global Gamma Valerolactone Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Gamma Valerolactone Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Gamma Valerolactone Sales Volume Share by Application (2021-2032) Figure 24. Global Gamma Valerolactone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Gamma Valerolactone Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Gamma Valerolactone Sales Value Share by Application (2021-2032) Figure 27. Global Gamma Valerolactone Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Gamma Valerolactone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Gamma Valerolactone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Gamma Valerolactone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Gamma Valerolactone Sales Value (2021-2032) & (US$ Million) Figure 32. North America Gamma Valerolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Gamma Valerolactone Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Gamma Valerolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Gamma Valerolactone Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Gamma Valerolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Gamma Valerolactone Sales Value (2021-2032) & (US$ Million) Figure 38. South America Gamma Valerolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Gamma Valerolactone Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Gamma Valerolactone Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Gamma Valerolactone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Gamma Valerolactone Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Gamma Valerolactone Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Industrial Grade
Applications
  • Food Flavors
  • Solvent
  • Monomer Intermediate
  • Others
Companies covered
  • Anhui Hyea Aromas
  • Dideu Industries
  • Kunshan Qiandeng Baihua
  • Zhongyue Aroma
  • Soda Aromatic
  • Inoue Perfumery MFG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gamma Valerolactone Sales Value (2021-2032)
  4. 1.2.2 Global Gamma Valerolactone Sales Volume (2021-2032)
  5. 1.2.3 Global Gamma Valerolactone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gamma Valerolactone Market Dynamics
  1. 2.1 Gamma Valerolactone Industry Trends
  2. 2.2 Gamma Valerolactone Industry Drivers
  3. 2.3 Gamma Valerolactone Industry Opportunities and Challenges
  4. 2.4 Gamma Valerolactone Industry Restraints
3 Gamma Valerolactone Market by Company
  1. 3.1 Global Gamma Valerolactone Company Revenue Ranking in 2025
  2. 3.2 Global Gamma Valerolactone Revenue by Company (2021-2026)
  3. 3.3 Global Gamma Valerolactone Sales Volume by Company (2021-2026)
  4. 3.4 Global Gamma Valerolactone Average Price by Company (2021-2026)
  5. 3.5 Global Gamma Valerolactone Company Ranking (2024-2026)
  6. 3.6 Global Gamma Valerolactone Company Manufacturing Base and Headquarters
  7. 3.7 Global Gamma Valerolactone Company Product Type and Application
  8. 3.8 Global Gamma Valerolactone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gamma Valerolactone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gamma Valerolactone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gamma Valerolactone Market by Type
  1. 4.1 Gamma Valerolactone Type Introduction
  2. 4.1.1 Food Grade
  3. 4.1.2 Industrial Grade
  4. 4.2 Global Gamma Valerolactone Sales Volume by Type
  5. 4.2.1 Global Gamma Valerolactone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gamma Valerolactone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gamma Valerolactone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gamma Valerolactone Sales Value by Type
  9. 4.3.1 Global Gamma Valerolactone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gamma Valerolactone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gamma Valerolactone Sales Value Share by Type (2021-2032)
5 Gamma Valerolactone Market by Application
  1. 5.1 Gamma Valerolactone Application Introduction
  2. 5.1.1 Food Flavors
  3. 5.1.2 Solvent
  4. 5.1.3 Monomer Intermediate
  5. 5.1.4 Others
  6. 5.2 Global Gamma Valerolactone Sales Volume by Application
  7. 5.2.1 Global Gamma Valerolactone Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Gamma Valerolactone Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Gamma Valerolactone Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Gamma Valerolactone Sales Value by Application
  11. 5.3.1 Global Gamma Valerolactone Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Gamma Valerolactone Sales Value by Application (2021-2032)
  13. 5.3.3 Global Gamma Valerolactone Sales Value Share by Application (2021-2032)
6 Gamma Valerolactone Regional Sales and Value Analysis
  1. 6.1 Global Gamma Valerolactone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gamma Valerolactone Sales by Region (2021-2032)
  3. 6.2.1 Global Gamma Valerolactone Sales by Region: 2021-2026
  4. 6.2.2 Global Gamma Valerolactone Sales by Region (2027-2032)
  5. 6.3 Global Gamma Valerolactone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gamma Valerolactone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gamma Valerolactone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gamma Valerolactone Sales Value by Region (2027-2032)
  9. 6.5 Global Gamma Valerolactone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gamma Valerolactone Sales Value (2021-2032)
  12. 6.6.2 North America Gamma Valerolactone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gamma Valerolactone Sales Value (2021-2032)
  15. 6.7.2 Europe Gamma Valerolactone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gamma Valerolactone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gamma Valerolactone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gamma Valerolactone Sales Value (2021-2032)
  21. 6.9.2 South America Gamma Valerolactone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gamma Valerolactone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gamma Valerolactone Sales Value Share by Country, 2025 VS 2032
7 Gamma Valerolactone Country-level Sales and Value Analysis
  1. 7.1 Global Gamma Valerolactone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gamma Valerolactone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gamma Valerolactone Sales by Country (2021-2032)
  4. 7.3.1 Global Gamma Valerolactone Sales by Country (2021-2026)
  5. 7.3.2 Global Gamma Valerolactone Sales by Country (2027-2032)
  6. 7.4 Global Gamma Valerolactone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gamma Valerolactone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gamma Valerolactone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gamma Valerolactone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gamma Valerolactone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gamma Valerolactone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anhui Hyea Aromas
  2. 8.1.1 Anhui Hyea Aromas Company Information
  3. 8.1.2 Anhui Hyea Aromas Business Overview
  4. 8.1.3 Anhui Hyea Aromas Gamma Valerolactone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Anhui Hyea Aromas Gamma Valerolactone Product Portfolio
  6. 8.1.5 Anhui Hyea Aromas Recent Developments
  7. 8.2 Dideu Industries
  8. 8.2.1 Dideu Industries Company Information
  9. 8.2.2 Dideu Industries Business Overview
  10. 8.2.3 Dideu Industries Gamma Valerolactone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dideu Industries Gamma Valerolactone Product Portfolio
  12. 8.2.5 Dideu Industries Recent Developments
  13. 8.3 Kunshan Qiandeng Baihua
  14. 8.3.1 Kunshan Qiandeng Baihua Company Information
  15. 8.3.2 Kunshan Qiandeng Baihua Business Overview
  16. 8.3.3 Kunshan Qiandeng Baihua Gamma Valerolactone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kunshan Qiandeng Baihua Gamma Valerolactone Product Portfolio
  18. 8.3.5 Kunshan Qiandeng Baihua Recent Developments
  19. 8.4 Zhongyue Aroma
  20. 8.4.1 Zhongyue Aroma Company Information
  21. 8.4.2 Zhongyue Aroma Business Overview
  22. 8.4.3 Zhongyue Aroma Gamma Valerolactone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zhongyue Aroma Gamma Valerolactone Product Portfolio
  24. 8.4.5 Zhongyue Aroma Recent Developments
  25. 8.5 Soda Aromatic
  26. 8.5.1 Soda Aromatic Company Information
  27. 8.5.2 Soda Aromatic Business Overview
  28. 8.5.3 Soda Aromatic Gamma Valerolactone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Soda Aromatic Gamma Valerolactone Product Portfolio
  30. 8.5.5 Soda Aromatic Recent Developments
  31. 8.6 Inoue Perfumery MFG
  32. 8.6.1 Inoue Perfumery MFG Company Information
  33. 8.6.2 Inoue Perfumery MFG Business Overview
  34. 8.6.3 Inoue Perfumery MFG Gamma Valerolactone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Inoue Perfumery MFG Gamma Valerolactone Product Portfolio
  36. 8.6.5 Inoue Perfumery MFG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gamma Valerolactone Value Chain Analysis
  2. 9.1.1 Gamma Valerolactone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gamma Valerolactone Sales Mode & Process
  6. 9.2 Gamma Valerolactone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gamma Valerolactone Distributors
  9. 9.2.3 Gamma Valerolactone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst